A multidisciplinary review of the science of vitamin D receptor activation

Kidney International Supplements

Volumn 1, Issue 4, 2011, Pages 107-110

  Cozzolino, Mario ^a   Bover, Jordi ^b   Vervloet, Marc ^c   Brandenburg, Vincent M ^d  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

cardio renal syndrome; chronic kidney disease; CKD MBD; vascular calcifi cation; VDR; VDR activation; vitamin D

Indexed keywords

EID: 84884553344     PISSN: 21571724     EISSN: 21571716     Source Type: Journal    
DOI: 10.1038/kisup.2011.25     Document Type: Editorial

References (13)

1. Ronco C, Cozzolino M. Mineral metabolism abnormalities and vitamin D receptor activation in cardiorenal syndromes. Heart Fail Rev; e-pub ahead of print 13 February 2011.
2. Adams JS, Hewison M. Update in vitamin D. J Clin Endocrinol Metab 2010; 95: 471-478.
3. West NE, Lechtzin N, Merlo CA et al. Appropriate goal level for 25-hydroxyvitamin D in cystic fibrosis. Chest; e-pub ahead of print 10 March 2011.
4. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press; 2011, p 1015. Full Report: http://books. nap.edu/openbook.php?record-id=13050. Brief Report: http://www.iom.edu/Reports/2010/Dietary-Reference-Intakes-for-Calcium-and- Vitamin-D/Report-Brief.aspx.
5. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42(4 Suppl 3): S1-S201.
6. Torregrosa JV, Bover J, Cannata Andía J et al. Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (SEN-MBD) Nefrologia 2011; 31(Suppl 1): 3-32.
7. Souberbielle JC, Body JJ, Lappe JM et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 2010; 9: 709-715.
8. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
9. Kidney-Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 2009; 113: S1-S130.
10. Melamed ML, Michos ED, Post W et al. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008; 168: 1629-1637.
11. Hsu JJ, Tintut Y, Demer LL. Vitamin D and osteogenic differentiation in the artery wall. Clin J Am Soc Nephrol 2008; 3: 1542-1547.
12. Melamed ML, Astor B, Michos ED et al. 25-hydroxyvitamin D levels, race, and the progression of kidney disease. J Am Soc Nephrol 2009; 20: 2631-2639.
13. Cozzolino M, Ketteler M, Zehnder D. The vitamin D system: a crosstalk between the heart and kidney. Eur J Heart Fail 2010; 12: 1031-1041.